Inhibiting human protein kinases, which are activated by the malaria parasite, could reduce the malaria burden, and researchers explore the use of AI in automating malaria diagnosis.
A peptide derived from Bacillus bacteria stimulates the production of T cells prophylactically and therapeutically, and researchers explore the use of satellite imagery to assess the suitability of malaria vectors in different geographies.
Scientists publish new insights into Plasmodium falciparum P2, and the IDDO launch an online tool to map the prevalence of substandard and falsified antimalarial drugs around the world.
Researchers find that the malaria parasite mimics a natural molecule that inhibits the release of NK cells, and the effect of insecticide resistance on the reproductive potential of Anopheles coluzzii mosquitoes has been revealed.
Zambian study reveals that mass drug administration is safe, logistically feasible, accepted by communities, and effective in reducing malaria prevalence in the short term, and the Medicines for Malaria Venture launch Malaria Libre, an open-source drug discovery programme.
The prevalence of insecticide resistance increases in Africa and researchers find that the malaria parasite interferes with red blood cell development to ensure gametocyte maturation.